FDA Approves Iloperidone (Fanapt) for Acute Treatment of Bipolar I Disorder
The FDA approved iloperidone for acute treatment of bipolar I disorder on April 02, 2024, according to Vanda Pharmaceuticals.
Source: hcplive.com
Bipolar Mania News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bipolar Mania. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Bipolar Mania Today - Breaking & Trending Today
FDA Approves Fanapt for Mixed, Manic Episodes Associated With Bipolar I Disorder
The atypical antipsychotic was approved for the acute treatment of schizophrenia in 2009.
Source: psychiatrictimes.com
Vanda Pharmaceuticals announces the publication of Efficacy and Safety of Iloperidone in Bipolar Mania: A Double-Blind, Placebo-Controlled Study in the Journal of Clinical Psychiatry -January 17, 2024 at 03:47 pm EST
WASHINGTON, Jan. 17, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. today announced the publication of an article titled Efficacy and Safety of Iloperidone in Bipolar Mania: A Double-Blind,...
Source: marketscreener.com
Vanda Pharmaceuticals announces the publication of Efficacy and Safety of Iloperidone in Bipolar Mania: A Double-Blind, Placebo-Controlled Study in the Journal of Clinical Psychiatry
/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the publication of an article titled "Efficacy and Safety of Iloperidone in...
Source: prnewswire.com
Bipolar Disorder May Raise Risk for PCOS
Previous studies suggest that the prevalence of polycystic ovary syndrome is higher in bipolar disorder patients compared with individuals not diagnosed with BD.
Source: medscape.com